Cargando…

Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15

The clinical outcome of colorectal cancer (CRC) is associated with the immune response; thus, these tumors could be responsive to different immune therapy approaches. Natural killer (NK) cells are key antitumor primary effectors that can eliminate CRC cells without prior immunization. We previously...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rocca, Yamila Sol, Roberti, María Paula, Juliá, Estefanía Paula, Pampena, María Betina, Bruno, Luisina, Rivero, Sergio, Huertas, Eduardo, Sánchez Loria, Fernando, Pairola, Alejandro, Caignard, Anne, Mordoh, José, Levy, Estrella Mariel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056190/ https://www.ncbi.nlm.nih.gov/pubmed/27777574 http://dx.doi.org/10.3389/fimmu.2016.00413

Ejemplares similares

Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer
por: Juliá, Estefanía Paula, et al.
Publicado: (2020)

Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells
por: Juliá, Estefanía Paula, et al.
Publicado: (2018)

High neutrophil to lymphocyte ratio and decreased CD69(+)NK cells represent a phenotype of high risk in early-stage breast cancer patients
por: Mandó, Pablo, et al.
Publicado: (2018)

Natural Killer Cells in Human Cancer: From Biological Functions to Clinical Applications
por: Levy, Estrella Mariel, et al.
Publicado: (2011)

Biological role of NK cells and immunotherapeutic approaches in breast cancer
por: Roberti, María P., et al.
Publicado: (2012)

Natural Killer Cells as Helper Cells in Dendritic Cell Cancer Vaccines
por: Pampena, María Betina, et al.
Publicado: (2015)

Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release
por: Pampena, María B., et al.
Publicado: (2017)

Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report
por: Aris, Mariana, et al.
Publicado: (2018)

Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice
por: Roberti, María Paula, et al.
Publicado: (2012)

Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants
por: Pampena, María B., et al.
Publicado: (2018)

IL-2–dependent adaptive control of NK cell homeostasis
por: Gasteiger, Georg, et al.
Publicado: (2013)

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study
por: Mordoh, José, et al.
Publicado: (2017)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

NK Cell IL-10 Production Requires IL-15 and IL-10 Driven STAT3 Activation
por: Clark, Sarah E., et al.
Publicado: (2019)

IL-1 receptor antagonist restores IL-18 NK cell axis in systemic JIA
por: Vastert, Sebastiaan J, et al.
Publicado: (2012)

IL-15 Promotes Polyfunctional NK Cell Responses to Influenza by Boosting IL-12 Production
por: Wagstaffe, Helen R., et al.
Publicado: (2018)

IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo
por: Haeberlein, Simone, et al.
Publicado: (2010)

TL1A Selectively Enhances IL-12/IL-18-Induced NK Cell Cytotoxicity against NK-Resistant Tumor Targets
por: Heidemann, Stephanie C., et al.
Publicado: (2010)

Sorgera' a Ginevra il sincrotrone più potente
por: Roberti, V
Publicado: (1955)

Regulation of NK Cell Activation and Effector Functions by the IL-12 Family of Cytokines: The Case of IL-27
por: Zwirner, Norberto Walter, et al.
Publicado: (2017)

Salmonella Induced IL-23 and IL-1β Allow for IL-12 Production by Monocytes and Mϕ1 through Induction of IFN-γ in CD56(+) NK/NK-Like T Cells
por: van de Wetering, Diederik, et al.
Publicado: (2009)

Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34(+) Progenitors Promoted by Membrane-Bound IL-15
por: Giuliani, Massimo, et al.
Publicado: (2008)

Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO mice
por: Matsuda, Masashi, et al.
Publicado: (2019)

Sarcoma IL-12 overexpression facilitates NK cell immunomodulation
por: Rademacher, Mary Jo, et al.
Publicado: (2021)

NK cells sense tumors, course of disease and treatments: Consequences for NK-based therapies
por: Fregni, Giulia, et al.
Publicado: (2012)

Induction of IL-22 protein and IL-22-producing cells in rainbow trout Oncorhynchus mykiss
por: Hu, Yehfang, et al.
Publicado: (2019)

IL-10(+) NK and TGF-β(+) NK cells play negative regulatory roles in HIV infection
por: Jiang, Yongjun, et al.
Publicado: (2018)

NK cell-derived IL-10 is critical for DC-NK cell dialogue at the maternal-fetal interface
por: Blois, Sandra M., et al.
Publicado: (2017)

A novel human IL2RB mutation results in T and NK cell–driven immune dysregulation
por: Fernandez, Isabel Z., et al.
Publicado: (2019)

IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets
por: Laroni, Alice, et al.
Publicado: (2011)

THE ROLE OF IL-13 AND NK T CELLS IN EXPERIMENTAL AND HUMAN ULCERATIVE COLITIS
por: Fuss, Ivan J., et al.
Publicado: (2008)

IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction
por: Easom, Nicholas J. W., et al.
Publicado: (2018)

Sialylation of Human Natural Killer (NK) Cells Is Regulated by IL-2
por: Rosenstock, Philip, et al.
Publicado: (2020)

Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12/15/18
por: Aarsund, Miriam, et al.
Publicado: (2022)

NK Cell Activation in Human Hantavirus Infection Explained by Virus-Induced IL-15/IL15Rα Expression
por: Braun, Monika, et al.
Publicado: (2014)

Correction: A novel human IL2RB mutation results in T and NK cell–driven immune dysregulation
por: Fernandez, Isabel Z., et al.
Publicado: (2019)

Implementation of a virtual multicenter gastrointestinal tumor board to reduce cancer disparities in Argentina
por: Esteso, Federico, et al.
Publicado: (2022)

IL‐18‐induced expression of high‐affinity IL‐2R on murine NK cells is essential for NK‐cell IFN‐γ production during murine Plasmodium yoelii infection
por: Stegmann, Kerstin A., et al.
Publicado: (2015)

A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer
por: Steele, N, et al.
Publicado: (2012)

IL-18–induced CD83(+)CCR7(+) NK helper cells
por: Mailliard, Robbie B., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_c09smlp6qgnhljbe57ad4iteo0